Literature DB >> 25176584

Preventing microbial colonisation of catheters: antimicrobial and antibiofilm activities of cellobiose dehydrogenase.

Barbara Thallinger1, Maya Argirova2, Magdalena Lesseva3, Roland Ludwig4, Christoph Sygmund4, Angelika Schlick1, Gibson S Nyanhongo5, Georg M Guebitz1.   

Abstract

The ability of cellobiose dehydrogenase (CDH) to produce hydrogen peroxide (H(2)O(2)) for antimicrobial and antibiofilm functionalisation of urinary catheters was investigated. A recombinantly produced CDH from Myriococcum thermophilum was shown to completely inhibit the growth of Escherichia coli and Staphylococcus aureus both in liquid and solid media when supplemented with either 0.8 mM or 2 mM cellobiose as substrate. Biofilm formation on silicone films was prevented by CDH when supplemented with 1mM cellobiose. The CDH/cellobiose system also successfully inhibited many common urinary catheter-colonising micro-organisms, including multidrug-resistant S. aureus, Staphylococcus epidermidis, Proteus mirabilis, Stenotrophomonas maltophilia, Acinetobacter baumannii and Pseudomonas aeruginosa. Interestingly, CDH was also able to produce H(2)O(2) during oxidation of extracellular polysaccharides (exPS) formed by micro-organisms in the absence of cellobiose. The H(2)O(2) production and consequently antimicrobial and antibiofilm activities on these exPS were enhanced by incorporation of glycoside hydrolases such as amylases. Hydrolysis of polysaccharides by these enzymes increases the number of terminal reducing sugars as substrates for CDH as well as destabilises the biofilm. Furthermore, CDH suspended in catheter lubricants killed bacteria in biofilms colonising catheters. Incorporation of the CDH/cellobiose system in the lubricant therefore makes it an easy strategy for preventing microbial colonisation of catheters.
Copyright © 2014 Elsevier B.V. and the International Society of Chemotherapy. All rights reserved.

Entities:  

Keywords:  Antibiofilm; Antimicrobial; Cellobiose dehydrogenase; Extracellular polysaccharides; Hydrogen peroxide; Urinary catheters

Mesh:

Substances:

Year:  2014        PMID: 25176584     DOI: 10.1016/j.ijantimicag.2014.06.016

Source DB:  PubMed          Journal:  Int J Antimicrob Agents        ISSN: 0924-8579            Impact factor:   5.283


  7 in total

1.  Characterization of Cellobiose Dehydrogenase from a Biotechnologically Important Cerrena unicolor Strain.

Authors:  Justyna Sulej; Grzegorz Janusz; Monika Osińska-Jaroszuk; Patrycja Rachubik; Andrzej Mazur; Iwona Komaniecka; Adam Choma; Jerzy Rogalski
Journal:  Appl Biochem Biotechnol       Date:  2015-05-24       Impact factor: 2.926

Review 2.  A review of the recent advances in antimicrobial coatings for urinary catheters.

Authors:  Priyadarshini Singha; Jason Locklin; Hitesh Handa
Journal:  Acta Biomater       Date:  2016-12-01       Impact factor: 8.947

3.  Activation of bacterial lytic polysaccharide monooxygenases with cellobiose dehydrogenase.

Authors:  Jennifer S M Loose; Zarah Forsberg; Daniel Kracher; Stefan Scheiblbrandner; Roland Ludwig; Vincent G H Eijsink; Gustav Vaaje-Kolstad
Journal:  Protein Sci       Date:  2016-09-26       Impact factor: 6.993

Review 4.  Biomodification Strategies for the Development of Antimicrobial Urinary Catheters: Overview and Advances.

Authors:  Sadiya Anjum; Surabhi Singh; Lepoittevin Benedicte; Philippe Roger; Manoj Panigrahi; Bhuvanesh Gupta
Journal:  Glob Chall       Date:  2017-12-27

5.  The antimicrobial activity of silver acetate against Acinetobacter baumannii in a Galleria mellonella infection model.

Authors:  Eden Mannix-Fisher; Samantha McLean
Journal:  PeerJ       Date:  2021-04-22       Impact factor: 2.984

Review 6.  Antimicrobial Activity of Films and Coatings Containing Lactoperoxidase System: A Review.

Authors:  Mojtaba Yousefi; Amene Nematollahi; Mahdi Shadnoush; Amir M Mortazavian; Nasim Khorshidian
Journal:  Front Nutr       Date:  2022-03-04

7.  Advances in the Microbiology of Stenotrophomonas maltophilia.

Authors:  Joanna S Brooke
Journal:  Clin Microbiol Rev       Date:  2021-05-26       Impact factor: 50.129

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.